{"name":"Degron Therapeutics Co.","slug":"degron-therapeutics-co","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxOajhYMHJVR3ZaNTRweW53M0NzX09YNlNOVnlDRi1aNkljaXQycmxETGJMU2dNckxPUGxDY2prcW1uRWo1aXFLSkc4N3p0Zk5VUFczdW4wbjBwdms3YVFkYXlmdDR1UkdIaG5SMDhJUTYweGJYSHMzYlBFNW9pdGRxRjhUNk43Q28zeV9YVlJhcms2WnZlV01wSzhpSEVfT2NJSHc?oc=5","date":"2025-12-04","type":"pipeline","source":"The Pharma Letter","summary":"TRIANA Biomedicines closes $120M Series B funding round - The Pharma Letter","headline":"TRIANA Biomedicines closes $120M Series B funding round","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxNNVF1QWFHMzlsLVg3UEU2NUFqalY0WmpQRGxrdWt6XzduZ1B3aXpOLWlKczQ0OWE1Q2QwbFlOVU9DcktxYUZoQmdzcERXSWI3NVlRNVhqeFM4MkMzV096X3FVR2Y4Rlp5VWlGVkwyd3BPZjhCMGFzLThKSFNqRTQ1eEhaNUhfdG1EQjhNUXhCczJ3anVvaUlIRFYwOUpwdUQtazNxSW1QcG4zUmFnQVJUSlVQT3Q?oc=5","date":"2025-09-01","type":"pipeline","source":"BioSpectrum Asia","summary":"Unlocking the Undruggable with Targeted Protein Degradation - BioSpectrum Asia","headline":"Unlocking the Undruggable with Targeted Protein Degradation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNT1RDcEVpdWtCZmlYcnkyTzNJaGdBQ2ZzRFoyVHVtamcwQzAyampKM1BOWURZeE0xNFMyMy15cV8wQjROdG9ZRUZwSVpjcTBQRno2ekNCZENrSk9FQURIajhyYzE2VUh6RFJhRkQ5R1NRa1FOUXJXbHhBMzAzbEE5dFJpcWJBSEZqcnRzQ0lodjVFNmlMUy1KeEk3VkI?oc=5","date":"2025-04-28","type":"regulatory","source":"Grand View Research","summary":"Molecular Glues Approved Drugs And Pipeline Analysis - Grand View Research","headline":"Molecular Glues Approved Drugs And Pipeline Analysis","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxOSU9pNFpHQVhSX0pDM05PWkk4cHFDUnc3VGloeFpqMHhHRlptVVFkMW9CM3hlTllwSTJIeUlSWHZyS3lGMG5JMklnQnZXZjRfeXZTNXhpeF9hZjZMemFacDhRTURGX2wyamIwbHRheUN6UmhCYUJzU056UmhUZGpNNTZrazJmMXk4SHlQcldBUnJPZ1pyaUdVQWlBYWxRbEZSb2c?oc=5","date":"2024-11-14","type":"pipeline","source":"DCAT Value Chain Insights","summary":"Bio/Pharma’s Rising Stars: The Companies Emerging on the Industry’s Radar - DCAT Value Chain Insights","headline":"Bio/Pharma’s Rising Stars: The Companies Emerging on the Industry’s Radar","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxOdUhaRFVacFN4cFE0TlN5UE1zX0Z2ZkNEMlM2bk56U043NnozUXcyZkZpTWVOVUhpMnc4aUZzNVlHMlBDeTdYSGlpdzZubHFobUFCLW96NXN6ZHB0ODd0dXhHNmRHckF5VGktNHdULWhwZmMxNExsNHVmWHNHdTd1ZklQYTM1RVpSbXBaelgySjNrX2VtSEE?oc=5","date":"2024-11-13","type":"pipeline","source":"C&EN","summary":"Big Pharma eyes a slew of molecular glues - C&EN","headline":"Big Pharma eyes a slew of molecular glues - C&EN","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE1pamRtU0NhbGlyY2M5aVE4a2swZC12MEJaRU1CVTJvb0NVbElpTVBJendjNnZsbFVTNXRTQXhnVjBwT3NqV1lJc2RzVnhkZ1pqYUt0aXZVVUxETnl5elRfRzFodkZZcERhWUsyTXpJWWhocWtZTDhPRnEzRzdiNlE?oc=5","date":"2024-06-21","type":"deal","source":"businessofsandiego.substack.com","summary":"Scoop: San Diego Biotech Partners with Takeda, Lands $1.2B Milestone Deal - businessofsandiego.substack.com","headline":"Scoop: San Diego Biotech Partners with Takeda, Lands $1.2B Milestone Deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_AFBVV95cUxOcFo0LUpwZjVYVGRQUHhlX2dRTldnUE9DN2ZVbUtBSFZDODZ2bk94Z2M5YTlFdkhBc3ZtZXhvS2NmMVhYZ0ZSNjdDbFh1czB2RTl4ZTRIY1EtQ19pcjhpQUN1S203Z3lNZDhhYUJoUmJMTnRrd1hOV2twZ3piMlVsLV9ld3FhRVBwdVE5N3Z4MGcxVl8zQk1TN1dTX0dyd0kzOTJRQmRhYXlGbXhXTTlnS2lpUWhsdG42S0NMVDhSM3U3X2VZTkFDVHI2X0Exa2NiSjROUE1FS1FTaTBwUDI3VWIxN09LYlV3R2hiV18tTXJ3clU5U0tmUnBsczU?oc=5","date":"2024-05-24","type":"deal","source":"Pharmaceutical Executive","summary":"Degron Therapeutics, Takeda Ink Exclusive License and Collaboration Agreement to Develop Molecule Degraders Targeting Multiple Indications - Pharmaceutical Executive","headline":"Degron Therapeutics, Takeda Ink Exclusive License and Collaboration Agreement to Develop Molecule Degraders Targeting Mu","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingJBVV95cUxPajh5Y3RnTmJCVVpXb3JGcG56dkZxYXNsSEFGX3hwNmxZNjR5TmhpNzhxREU2OE43Q2hfdjNIdlNTWEFCczhCWGxPckhjZTEwQk14bHRrVEdPWlVqSndhbEN5Y1l3THhydmEwd2RoZEhscUdwMEZfSmo4a0dxTGUyYlRUakc5M014ZkZPamdDOEZlQS1kdmxxWFhqT1VGM1N6T1VQV2JwbEp2N3BMaUJrNFJ4SG5MTkg5d3NCRV8zel8zV3NSa3VvMEhBdkRnM3l0c3Z0SDRrT1JlbVE1MG5FOFRZV1J1WTduSF9ub2pXWXZVQmVfY3FGb1BrZjBTYVMzdVVVNXBCTkVTUktZYWhzYkZFNldncWZhXzRKbWR3?oc=5","date":"2024-05-23","type":"deal","source":"PR Newswire","summary":"Degron Therapeutics Announces Multi-Target Collaboration and Exclusive License Agreement with Takeda to Discover Molecular Glue Degraders - PR Newswire","headline":"Degron Therapeutics Announces Multi-Target Collaboration and Exclusive License Agreement with Takeda to Discover Molecul","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxQc24yQ0thOEFONnRweG1naUlXNEhjanpxbGpXeDNXV0xNVkVXSzc2Q1B6NHhWSG1ZNU1TWlhZTTBBNUhtSjR4Qm5MdUhRUmJxeDk0RHQ5Ti1idEQxQl9yX1hCWW9oQWFCLVhCWWFSbzl3NDRyeEw3NGZSUDBIdXBEVmRLZmtnUjBFZTVaNjA3VmJ5YjFjUEQ5bzFXVDk2cGVGR0VTWjVpUQ?oc=5","date":"2024-05-23","type":"deal","source":"Fierce Biotech","summary":"Takeda gets crafty with $1.2B biobucks deal to create molecular glues with Degron - Fierce Biotech","headline":"Takeda gets crafty with $1.2B biobucks deal to create molecular glues with Degron","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxPMFlZWUdWU0NBTXFBaTE2bjk3b2FubFZteXJOemxUdWZiS3Q0R1lnNE9UU2xld19WaUJrbkRpZEMtcE1DWVVPZ3JJZTRmNXd6SFJEcFBsLUZYbXJCcEdjQVo4dGQ2THg1MlVOb0w5Qk1YUFlWblJRSFRmWEpGcUNWa08tRldYdTgwakxTMXB5MTlCdUlpak1iWmI4Wkl4dw?oc=5","date":"2024-05-23","type":"deal","source":"BioWorld News","summary":"Degron, Takeda bind $1.2B deal for molecular glue degraders - BioWorld News","headline":"Degron, Takeda bind $1.2B deal for molecular glue degraders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTFAtN01TS2Q3RnB2ZGZxeGVwcWdhTXZZVVdPcV8zLXhRTm5Ub2lCNU9nOXdfbkx5T2Z3UnF0clgxMnM1eE5OSXFDXzNiMllkU1ZCQm1GSEhVTnR3R0YwekR4WEltQWJRaWthM3IwdDV2WDc?oc=5","date":"2023-10-24","type":"pipeline","source":"Labiotech.eu","summary":"Seven molecular glue startups looking to stick around in the biotech industry - Labiotech.eu","headline":"Seven molecular glue startups looking to stick around in the biotech industry","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgJBVV95cUxNSFpLdndnWHRRenVRYzlJSUgwSkVhLWY3SDJIRXIyNVRkRUV0XzJIVHpDNms0bVFJQ2xKNTdiZTZlb2FKTWlsbzRwclA5c2pXa0hGaktXN1VveVhhVUVSdDNpbHlqU3BwalVNMUcyNXBZZUFKZXBIRkk5U195eVhwWk8xWjFsR25fS3pGRzd4ZGZaeHlWTlhxbzI4dDJzT3pGMUt5V05ZZmh6MkJzYWlzNVVSdXVfR2taRENFNW44QzBGcDhvNzAyaW5sRVVwbjZjcmU5T0ZBYkIyZjhycWdPdDZNY1VQYUp1MW5wdHRrbDRMWWkwWjdWS0hZbVMyTWprUWttTGg4bVNvLXozRUp4VEFjUExrc3NOcWZRNzRXVjdHTHpsNlVaVzk4V1cwZXEtbVlqajlR?oc=5","date":"2022-06-09","type":"pipeline","source":"PR Newswire","summary":"Degron Therapeutics Raises $22M Series A Financing to Accelerate Growth and Expand Molecular-Glue-Based Targeted Protein Degradation Drug Discovery Platform - PR Newswire","headline":"Degron Therapeutics Raises $22M Series A Financing to Accelerate Growth and Expand Molecular-Glue-Based Targeted Protein","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}